查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1584741

抗生素市场：按作用机制、药物类别、频谱、类别、应用、给药途径、分销管道 - 2025-2030 年全球预测

Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年抗生素市值为430.8亿美元，预计2024年将达到457.4亿美元，复合年增长率为6.81%，到2030年将达到683.5亿美元。

抗生素市场涉及寻找透过杀死细菌或抑制细菌生长来对抗细菌感染的药物。此系列包括各种类别，如 β-内酰胺类、四环霉素、大环内酯类、Aminoglycosides等，涵盖人类健康、兽医用途和农业用途。对抗生素的需求源于它们在治疗细菌性疾病、预防感染疾病传播和保护公众健康方面的重要作用，这使得它们在手术、癌症治疗和流行病期间作为预防药物尤其重要。最终用途范围从医院、诊所、家庭保健到畜牧业，抗生素可提高生产力并保护牲畜的健康。细菌感染的增加、医疗保健改善导致新兴市场的需求增加以及对抗抗药性菌株的抗生素配方创新推动了成长。潜在的机会在于开发窄频谱、利用生物技术开发新型抗菌药物以及投资快速诊断技术以更精确地调整抗生素的使用。然而，抗生素抗药性、监管障碍和抗生素生产盈利下降等挑战正在阻碍市场扩张。也有一些局限性，例如抗生素的过度使用和滥用可能导致多重抗药性细菌的出现，以及关于在家畜中使用抗生素的争论可能导致抗药性细菌的出现。在创新方面，重点研究胜肽、探索与免疫疗法的协同效应以及人工智慧驱动的药物发现有助于推动产业成长。技术创新的潜在领域包括开发突破抗药性的分子和次世代定序技术，以提高抗生素部署的准确性，这表明市场有能力实现技术主导的转型。儘管抗生素市场面临许多挑战，但对创新和监管合作的策略重点可以为这个重要医疗保健产业的持续成长和市场开拓铺平道路。

主要市场统计
基准年[2023] 430.8亿美元
预测年份 [2024] 457.4亿美元
预测年份 [2030] 683.5亿美元
复合年增长率（%） 6.81%

市场动态：揭示快速发展的抗生素市场的关键市场洞察

供需的动态交互作用正在改变抗生素市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球感染疾病和慢性病盛行率不断上升
    • 倾向于疾病的早期诊断和治疗
    • 新抗生素测试开发的临床试验数量增加
  • 市场限制因素
    • 对抗生素抗药性的担忧
  • 市场机会
    • 治疗抗生素抗药性微生物感染疾病的先进前景分子和新型联合治疗
    • 加大开发新药研发投入
  • 市场挑战
    • 使用抗生素的副作用

波特五力：驾驭抗生素市场的策略工具

波特的「五力」框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解抗生素市场的外部影响

外部宏观环境因素对抗生素市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解抗生素市场的竞争状况

抗生素市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵抗生素市场供应商绩效评估

FPNV定位矩阵是评估抗生素市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製抗生素市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，抗生素市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地感染疾病和慢性病的盛行率正在增加。
      • 疾病的早​​期诊断和治疗趋势
      • 新药开发的临床试验数量增加抗生素

测试

    • 抑制因素
      • 与抗生素抗药性相关的担忧
    • 机会
      • 先进的有潜力的分子和新的联合治疗可治疗抗生素抗药性微生物感染疾病
      • 加大开发新药的研发投入
    • 任务
      • 使用抗生素的副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 抗生素市场行动机制

  • 细胞壁合成抑制剂
  • DNA合成抑制剂
  • 霉菌酸抑制剂
  • 蛋白质合成抑制剂
  • RNA合成抑制剂

第七章依药物类别分類的抗生素市场

  • Aminoglycosides
  • 碳青霉烯类
  • 头孢菌素
  • Fluoroquinolones
  • 大环内酯
  • 青霉素
  • 磺胺类药物

第八章抗生素市场频谱

  • 抗生素种类广泛
  • 窄效抗生素

第九章抗生素市场：依类别

  • 品牌抗生素
  • 常见抗生素

第10章抗生素市场：依应用分类

  • 耳部感染疾病
  • 胃肠道感染疾病
  • 呼吸道感染疾病
  • 败血症
  • 皮肤感染疾病
  • 尿道感染

第十一章抗生素市场：依给药途径

  • 口服
  • 胃肠外的

第十二章抗生素市场：按分销管道

  • 离线
  • 在线的

第十三章美洲抗生素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第14章亚太地区抗生素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十五章欧洲、中东和非洲抗生素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Amneal Pharmaceuticals LLC
  • Astellas Pharma, Inc.
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cadila Healthcare Ltd.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Glenmark Pharmaceuticals Limited
  • Hetero Healthcare
  • Johnson & Johnson Services, Inc.
  • KYORIN Holdings, Inc.
  • Lupin Limited
  • Melinta Therapeutics, Inc.
  • Merck & Co., Inc.
  • MerLion Pharmaceuticals GmbH
  • Mylan NV by Viatris
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Shionogi & Co., Ltd.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-434CCDA0512F

The Antibiotics Market was valued at USD 43.08 billion in 2023, expected to reach USD 45.74 billion in 2024, and is projected to grow at a CAGR of 6.81%, to USD 68.35 billion by 2030.

The antibiotics market encompasses the investigation of drugs that combat bacterial infections by either killing bacteria or hindering their growth. Its scope includes various classes such as beta-lactams, tetracyclines, macrolides, aminoglycosides, and others, spanning applications in human health, veterinary use, and agricultural purposes. The necessity for antibiotics arises from their crucial role in treating bacterial diseases, preventing the spread of infections, and safeguarding public health, notably essential in surgeries, cancer treatment, and as prophylaxis during pandemics. End-use scopes range widely from hospitals, clinics, and home healthcare settings to animal husbandry, where antibiotics enhance productivity and safeguard livestock health. Growth is propelled by increasing bacterial infections, rising demand in emerging markets due to improved healthcare, and innovations in antibiotic formulations combating resistant strains. Potential opportunities lie in the development of narrow-spectrum antibiotics, leveraging biotechnology for novel antimicrobial agents, and investing in rapid diagnostic technologies that tailor antibiotic use more precisely. However, challenges such as antibiotic resistance, regulatory hurdles, and the decline in antibiotic production profitability impede market expansion. Limitations include the overuse and misuse of antibiotics, leading to the emergence of multi-drug-resistant organisms, and debates surrounding the use of antibiotics in livestock contributing to resistance. For innovation, focus on research in antimicrobial peptides, exploring synergies with immunotherapy, and leveraging AI for drug discovery can steer industry growth. Viable areas for innovation include developing resistance-breaking molecules and next-generation sequencing technology to improve precision in antibiotic deployment, suggesting a market poised for technologically driven transformation. Thus, while the antibiotics market encounters numerous challenges, strategic focus on innovation and regulatory collaboration can open pathways for sustainable growth and development in this critical healthcare sector.

KEY MARKET STATISTICS
Base Year [2023] USD 43.08 billion
Estimated Year [2024] USD 45.74 billion
Forecast Year [2030] USD 68.35 billion
CAGR (%) 6.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antibiotics Market

The Antibiotics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious and chronic diseases worldwide
    • Inclination toward early diagnosis and treatment of diseases
    • Rise in the number of clinical trials for the development of novel antibiotics trials
  • Market Restraints
    • Concerns associated with antibiotics resistance
  • Market Opportunities
    • Advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections
    • Growing in R&D and investments for the development of new drugs
  • Market Challenges
    • Side effects caused by the usage of antibiotic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Antibiotics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antibiotics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antibiotics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antibiotics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antibiotics Market

A detailed market share analysis in the Antibiotics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antibiotics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antibiotics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antibiotics Market

A strategic analysis of the Antibiotics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antibiotics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc., Bausch Health Companies, Inc., Bayer AG, Bristol-Myers Squibb Company, Cadila Healthcare Ltd., Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, Glenmark Pharmaceuticals Limited, Hetero Healthcare, Johnson & Johnson Services, Inc., KYORIN Holdings, Inc., Lupin Limited, Melinta Therapeutics, Inc., Merck & Co., Inc., MerLion Pharmaceuticals GmbH, Mylan N.V. by Viatris, Novartis International AG, Pfizer Inc., Sanofi S.A., Shionogi & Co., Ltd., Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Antibiotics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Action Mechanism, market is studied across Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors.
  • Based on Drug Class, market is studied across Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, Macrolides, Penicillin, and Sulfonamides.
  • Based on Spectrum, market is studied across Broad-spectrum Antibiotics and Narrow-spectrum Antibiotics.
  • Based on Category, market is studied across Branded Antibiotics and Generic Antibiotics.
  • Based on Application, market is studied across Ear Infection, Gastrointestinal Infections, Respiratory Infections, Septicemia, Skin Infections, and Urinary Tract Infections.
  • Based on Route of Administration, market is studied across Oral and Parenteral.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Inclination toward early diagnosis and treatment of diseases
      • 5.1.1.3. Rise in the number of clinical trials for the development of novel antibiotics

trials

    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with antibiotics resistance
    • 5.1.3. Opportunities
      • 5.1.3.1. Advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections
      • 5.1.3.2. Growing in R&D and investments for the development of new drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects caused by the usage of antibiotic drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antibiotics Market, by Action Mechanism

  • 6.1. Introduction
  • 6.2. Cell Wall Synthesis Inhibitors
  • 6.3. DNA Synthesis Inhibitors
  • 6.4. Mycolic Acid Inhibitors
  • 6.5. Protein Synthesis Inhibitors
  • 6.6. RNA Synthesis Inhibitors

7. Antibiotics Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Aminoglycosides
  • 7.3. Carbapenem
  • 7.4. Cephalosporin
  • 7.5. Fluoroquinolone
  • 7.6. Macrolides
  • 7.7. Penicillin
  • 7.8. Sulfonamides

8. Antibiotics Market, by Spectrum

  • 8.1. Introduction
  • 8.2. Broad-spectrum Antibiotics
  • 8.3. Narrow-spectrum Antibiotics

9. Antibiotics Market, by Category

  • 9.1. Introduction
  • 9.2. Branded Antibiotics
  • 9.3. Generic Antibiotics

10. Antibiotics Market, by Application

  • 10.1. Introduction
  • 10.2. Ear Infection
  • 10.3. Gastrointestinal Infections
  • 10.4. Respiratory Infections
  • 10.5. Septicemia
  • 10.6. Skin Infections
  • 10.7. Urinary Tract Infections

11. Antibiotics Market, by Route of Administration

  • 11.1. Introduction
  • 11.2. Oral
  • 11.3. Parenteral

12. Antibiotics Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Offline
  • 12.3. Online

13. Americas Antibiotics Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Antibiotics Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Antibiotics Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amneal Pharmaceuticals LLC
  • 3. Astellas Pharma, Inc.
  • 4. Bausch Health Companies, Inc.
  • 5. Bayer AG
  • 6. Bristol-Myers Squibb Company
  • 7. Cadila Healthcare Ltd.
  • 8. Dr. Reddy's Laboratories
  • 9. Eli Lilly and Company
  • 10. F. Hoffmann-La Roche AG
  • 11. Glenmark Pharmaceuticals Limited
  • 12. Hetero Healthcare
  • 13. Johnson & Johnson Services, Inc.
  • 14. KYORIN Holdings, Inc.
  • 15. Lupin Limited
  • 16. Melinta Therapeutics, Inc.
  • 17. Merck & Co., Inc.
  • 18. MerLion Pharmaceuticals GmbH
  • 19. Mylan N.V. by Viatris
  • 20. Novartis International AG
  • 21. Pfizer Inc.
  • 22. Sanofi S.A.
  • 23. Shionogi & Co., Ltd.
  • 24. Sun Pharmaceutical Industries Limited
  • 25. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ANTIBIOTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIBIOTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIBIOTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTIBIOTICS MARKET SIZE, BY BRANDED ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTIBIOTICS MARKET SIZE, BY GENERIC ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTIBIOTICS MARKET SIZE, BY EAR INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANTIBIOTICS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANTIBIOTICS MARKET SIZE, BY SEPTICEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ANTIBIOTICS MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ANTIBIOTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ANTIBIOTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ANTIBIOTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 331. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 332. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023